New HIV Cure Case Offers Hope for Future Gene Therapies

An anonymous adult male, known as "The Next Berlin Patient," has been declared the seventh person cured of HIV. His case provides valuable insights that could lead to more accessible treatment approaches for the 39 million people living with HIV worldwide. The name pays homage to Timothy Ray Brown, the first person cured of HIV, initially known as "The Berlin Patient."

Immunologist Christian Gaebler of Charité – Berlin University Medicine will present this groundbreaking case at the 25th International AIDS Conference in Munich. The patient, diagnosed with HIV in 2009 and later with acute myeloid leukemia, received a hematopoietic stem cell transplant in 2015 from a donor with a rare heterozygous delta-32 CCR5 mutation. This mutation provides natural resistance to HIV by preventing the virus from binding to white blood cells.

Despite having a functional CCR5 receptor in his body, the patient has remained in treatment-free HIV remission since 2018. Gaebler's team hypothesizes that the transplant eradicated the infected white blood cells, replacing them with virus-free cells, while the mutated receptors prevent viral rebound. This case, with nearly six years of clinical follow-up, provides crucial evidence supporting the potential of gene therapies in curing HIV.

The significance of this case lies in its demonstration that even a single mutated copy of the delta-32 gene might suffice to cure HIV. This finding is pivotal for the development of gene therapies and reaffirms the importance of eliminating the viral reservoir for long-term remission. Although bone marrow transplants are not feasible for widespread HIV treatment, this case offers hope for future therapeutic advancements.

Click here to read the original news story.